• APMD share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • APMD stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • APMD market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About APMD

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • APMD market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest APMD news

No recent TipRanks articles are available for APMD

No recent press releases are available for APMD

APMD Financials

1-year income & revenue

  • APMD total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • APMD net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • APMD earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

APMD Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

APMD Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    APMD's competitors are included in the Health Technology sector and Biotechnology group

  • APMD market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news